Skip to main content
. 2012 Jan 18;2012(1):CD007678. doi: 10.1002/14651858.CD007678.pub2

Comparison 4. Complete response rate.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
1 All trials (previously untreated patients) 2 535 Risk Ratio (M‐H, Random, 95% CI) 1.11 [0.64, 1.92]
2 Rituximab‐containing regimen (previously untreated patients) 2 535 Risk Ratio (M‐H, Random, 95% CI) 1.11 [0.64, 1.92]
2.1 Rituximab in both arms 1 134 Risk Ratio (M‐H, Random, 95% CI) 1.37 [1.11, 1.70]
2.2 No rituximab in both arms 1 401 Risk Ratio (M‐H, Random, 95% CI) 0.84 [0.53, 1.33]